1. Ariad CEO to Retire Due to Pressure From Shareholders

    Ariad CEO to Retire Due to Pressure From Shareholders

    Harvey Berger, who co-founded Ariad Pharmaceuticals 23 years ago and oversaw the development and launch of its leukemia drug, Iclusig, is stepping down after months of pressure from shareholders and board members...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned

  3. Authors